Lipoprotein Size and Atherosclerosis Susceptibility in Apoe−/− and Ldlr−/− Mice

MM Véniant, S Withycombe… - … , thrombosis, and vascular …, 2001 - Am Heart Assoc
MM Véniant, S Withycombe, SG Young
Arteriosclerosis, thrombosis, and vascular biology, 2001Am Heart Assoc
Two hypercholesterolemic mouse models, the apo-E–deficient mouse (Apoe−/−) and the
LDL receptor–deficient mouse (Ldlr−/−), have been used extensively as animal models of
atherogenesis. Total plasma cholesterol levels in chow-fed Apoe−/− mice are much higher
than in Ldlr−/− mice. In a recent study, we managed to even-up the cholesterol levels in
Apoe−/− mice and Ldlr−/− mice by making both models homozygous for the Apob 100 (apo
B-100–only) allele. On a chow diet, apo-E–deficient apo B-100–only mice (Apoe−/− Apob …
Two hypercholesterolemic mouse models, the apo-E–deficient mouse (Apoe−/−) and the LDL receptor–deficient mouse (Ldlr−/−), have been used extensively as animal models of atherogenesis. Total plasma cholesterol levels in chow-fed Apoe−/− mice are much higher than in Ldlr−/− mice. In a recent study, we managed to even-up the cholesterol levels in Apoe−/− mice and Ldlr−/− mice by making both models homozygous for the Apob100 (apo B-100–only) allele. On a chow diet, apo-E–deficient apo B-100–only mice (Apoe−/−Apob100/100) and LDL receptor–deficient apo B-100–only mice (Ldlr−/−Apob100/100) had similar total plasma cholesterol levels (≈300 mg/dL). The plasma of Ldlr−/−Apob100/100 mice contained large numbers of small lipoproteins, whereas the plasma of Apoe−/−Apob100/100 mice contained much lower levels of much larger lipoproteins. Interestingly, the Ldlr−/−Apob100/100 mice developed far more extensive atherosclerotic lesions than the Apoe−/−Apob100/100 mice. The finding of substantially more atherosclerosis in Ldlr−/−Apob100/100 mice than in Apoe−/−Apob100/100 mice, despite nearly identical cholesterol levels, suggests that large numbers of small apo B-100–containing lipoproteins are far more atherogenic than lower numbers of large apo B-100–containing lipoproteins.
Am Heart Assoc